• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
Simplifying Antidepressant Quantification in Clinical Labs

Simplifying Antidepressant Quantification in Clinical Labs

by Morgana Moretti, PhD | Mar 23, 2023 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Emerging Tests-dtet

A recent study provides insights on how to use automation and only 20 μL of a serum sample to quantify blood levels of antidepressants.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Weekly Enforcement Report: UDTs & Diagnostic Imaging

Weekly Enforcement Report: UDTs & Diagnostic Imaging

by Rachel Muenz | Mar 22, 2023 | News, Open Content

This week’s cases involved false billing allegations related to urine drug testing, as well as diagnostic imaging false claims and fraud.

Weekly Enforcement Report: Lab Owners Charged in 2 Fraud Schemes

Weekly Enforcement Report: Lab Owners Charged in 2 Fraud Schemes

by Rachel Muenz | Mar 15, 2023 | News, Open Content

The owners face fraud charges in two different schemes, one involving urine drug testing and one involving COVID-19 testing.

Labs Should Be Wary of Improper Billing of G0483 Testing

Labs Should Be Wary of Improper Billing of G0483 Testing

by Glenn S. Demby | Mar 10, 2023 | News, Open Content

Recent OIG report says Medicare could have saved up to $215.8 million on at-risk payments for G0483 definitive drug tests.

OIG Sounds the Warning on Overbilling of G0483 Definitive Drug Tests

OIG Sounds the Warning on Overbilling of G0483 Definitive Drug Tests

by Glenn S. Demby | Mar 6, 2023 | News, Open Content

Labs may be billing Medicare for high-reimbursing and medically unnecessary drug tests, according to the OIG.

« Older Entries
Next Entries »

Sign up for our free weekly Lab & Pathology Insider email newsletter

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com